Personal information

Verified email addresses

Biography

Professor Li has accumulated 27 years of experience in the fields of urology and andrology. His primary research focus lies in prostate cancer, with a particular emphasis on investigating drug resistance in castration-resistant prostate cancer. In terms of clinical expertise, he possesses exceptional skills in the treatment of urological and andrological conditions, as well as various diseases. He has conducted extensive research on prostate diseases, male sexual dysfunction, male infertility, adrenal diseases, kidney and bladder tumors, while also successfully performing kidney transplantation surgeries. Notably proficient in laparoscopic minimally invasive surgery techniques, he has completed numerous operations including laparoscopic adrenal resection, laparoscopic kidney resection for radical treatment of kidney cancer, pyeloplasty procedures for urinary tract reconstruction, ureterotomy interventions for ureteral disorders, and lithotomy procedures for stone removal. Additionally demonstrating remarkable proficiency in electrovaporization resection of the prostate and minimally invasive tension-free suspension surgery for female stress urinary incontinence cases further establishes him as an expert and leading figure within Hebei Province's field of laparoscopic minimally invasive surgery and kidney transplantation.

Activities

Employment (1)

Third Hospital of Hebei Medical University: Shijiazhuang, Hebei province, CN

2012-01-01 to present | Director of department (Department of Urology,)
Employment
Source: Self-asserted source
Wenping Li

Education and qualifications (2)

Hebei Medical University: Shijiazhuang, CN

1993-09-01 to 1996-07-01 (graduate education)
Education
Source: Self-asserted source
Wenping Li

Hebei Medical University: Shijiazhuang, Hebei province, CN

1979-09-01 to 1984-07-01 (undergraduate education)
Education
Source: Self-asserted source
Wenping Li

Professional activities (3)

Hebei Sexology Association: Shijiazhuang, CN

2019-02-01 to present | President of the Association
Membership
Source: Self-asserted source
Wenping Li

Hebei Province Association of Integrative Chinese and Western Medicine: Shijiazhuang, CN

2018-03-01 to present | Chairman of committee (Urology Association)
Membership
Source: Self-asserted source
Wenping Li

Chinese Association of the Integration of Traditional and Western Medicine: Beijing, CN

2016-09-01 to present | Standing Committee Member (Urology Association)
Membership
Source: Self-asserted source
Wenping Li

Funding (4)

Effect of varicocele on semen quality

Award
Department of Health of Hebei Province (Shijiazhuang, Hebei province, CN)
Source: Self-asserted source
Wenping Li

Myogenic stem cell transplantation for treatment of type III stress urinary incontinence

Award
Department of Health of Hebei Province (Shijiazhuang, Hebei province, CN)
Source: Self-asserted source
Wenping Li

Study on androgen resistance mechanism of prostate cancer

Award
Hebei Provincial Department of Finance (Shijiazhuang, Hebei province, CN)
Source: Self-asserted source
Wenping Li

Study on the relationship between PCDH10-Malat1-AR-V7 regulatory axis and drug resistance in prostate cancer and its molecular mechanism

Award
Hebei Provincial Department of Finance (Shijiazhuang, Hebei province, CN)
Source: Self-asserted source
Wenping Li

Works (9)

A circadian rhythm-related gene signature for predicting relapse risk and immunotherapeutic effect in prostate adenocarcinoma

Aging
2022-09-14 | Journal article
Part of ISSN: 1945-4589
Contributors: Jin Liu; Zhao Tan; Shijie Yang; Xinda Song; Wenping Li
Source: Self-asserted source
Wenping Li

前列腺癌的免疫治疗研究进展

中华男科学杂志
2022-08-04 | Review
Contributors: Wenping Li
Source: Self-asserted source
Wenping Li

前列腺癌耐药性与雄激素受体剪接变异体 7 关系的研究进展

中华 实验外科杂志
2019-12-04 | Review
Contributors: Wenping Li
Source: Self-asserted source
Wenping Li

Prognostic Value of Protocadherin10 (PCDH10) Methylation in Serum of Prostate Cancer Patients.

Medical science monitor : international medical journal of experimental and clinical research
2016-02-16 | Journal article
Contributors: Wenping Li
Source: Self-asserted source
Wenping Li

Aberrant Protocadherin17 (PCDH17) Methylation in Serum is a Potential Predictor for Recurrence of Early-Stage Prostate Cancer Patients After Radical Prostatectomy.

Medical science monitor : international medical journal of experimental and clinical research
2015-12-19 | Journal article
Contributors: Wenping Li
Source: Self-asserted source
Wenping Li

代谢综合征与勃起功能障碍相关性研究

中华内分泌 外科杂志
2015-09-01 | Review
Contributors: Wenping Li
Source: Self-asserted source
Wenping Li

Promoter methylation of protocadherin8 is an independent prognostic factor for biochemical recurrence of early-stage prostate cancer.

Medical science monitor : international medical journal of experimental and clinical research
2014-12-08 | Journal article
Contributors: Wenping Li
Source: Self-asserted source
Wenping Li

Aberrant methylation of PCDH10 predicts worse biochemical recurrence-free survival in patients with prostate cancer after radical prostatectomy.

Medical science monitor : international medical journal of experimental and clinical research
2014-08-03 | Journal article
Contributors: Wenping Li
Source: Self-asserted source
Wenping Li

Aberrant promoter methylation of the cadherin 13 gene in serum and its relationship with clinicopathological features of prostate cancer.

The Journal of international medical research
2014-07-11 | Journal article
Contributors: Wenping Li
Source: Self-asserted source
Wenping Li